331 related articles for article (PubMed ID: 2740349)
1. Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1.
Twu JS; Chu K; Robinson WS
Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5168-72. PubMed ID: 2740349
[TBL] [Abstract][Full Text] [Related]
2. Identification of a region within the human immunodeficiency virus type 1 long terminal repeat that is essential for transactivation by the hepatitis B virus gene X.
Twu JS; Rosen CA; Haseltine WA; Robinson WS
J Virol; 1989 Jun; 63(6):2857-60. PubMed ID: 2724417
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus X gene can transactivate heterologous viral sequences.
Twu JS; Robinson WS
Proc Natl Acad Sci U S A; 1989 Mar; 86(6):2046-50. PubMed ID: 2538828
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus X protein transactivates the long terminal repeats of human immunodeficiency virus types 1 and 2.
Levrero M; Balsano C; Natoli G; Avantaggiati ML; Elfassi E
J Virol; 1990 Jun; 64(6):3082-6. PubMed ID: 2335828
[TBL] [Abstract][Full Text] [Related]
5. trans-activation of viral enhancers including long terminal repeat of the human immunodeficiency virus by the hepatitis B virus X protein.
Siddiqui A; Gaynor R; Srinivasan A; Mapoles J; Farr RW
Virology; 1989 Apr; 169(2):479-84. PubMed ID: 2705309
[TBL] [Abstract][Full Text] [Related]
6. Human hepatitis B virus enhancer 1 is responsive to human interleukin-6.
Ohno H; Kaneko S; Kobayashi K; Murakami S
J Med Virol; 1997 Aug; 52(4):413-8. PubMed ID: 9260690
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-alpha induces a kappa B sequence-specific DNA-binding protein in human hepatoblastoma HepG2 cells.
Banerjee R; Karpen S; Siekevitz M; Lengyel G; Bauer J; Acs G
Hepatology; 1989 Dec; 10(6):1008-13. PubMed ID: 2555296
[TBL] [Abstract][Full Text] [Related]
8. Synergistic activation of simian immunodeficiency virus and human immunodeficiency virus type 1 transcription by retinoic acid and phorbol ester through an NF-kappa B-independent mechanism.
Maciaszek JW; Talmage DA; Viglianti GA
J Virol; 1994 Oct; 68(10):6598-604. PubMed ID: 8083995
[TBL] [Abstract][Full Text] [Related]
9. Repeated B motifs in the human immunodeficiency virus type I long terminal repeat enhancer region do not exhibit cooperative factor binding.
Gaynor RB; Kuwabara MD; Wu FK; Garcia JA; Harrich D; Briskin M; Wall R; Sigman DS
Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9406-10. PubMed ID: 3200827
[TBL] [Abstract][Full Text] [Related]
10. Induction of human interferon gene expression is associated with a nuclear factor that interacts with the NF-kappa B site of the human immunodeficiency virus enhancer.
Hiscott J; Alper D; Cohen L; Leblanc JF; Sportza L; Wong A; Xanthoudakis S
J Virol; 1989 Jun; 63(6):2557-66. PubMed ID: 2542571
[TBL] [Abstract][Full Text] [Related]
11. Phorbol ester reduces constitutive nuclear NF kappa B and inhibits HIV-1 production in mature human monocytic cells.
Mufson RA; Myers C; Turpin JA; Meltzer M
J Leukoc Biol; 1992 Dec; 52(6):637-44. PubMed ID: 1464736
[TBL] [Abstract][Full Text] [Related]
12. The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus.
Doerre S; Sista P; Sun SC; Ballard DW; Greene WC
Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1023-7. PubMed ID: 8430069
[TBL] [Abstract][Full Text] [Related]
13. Inducible transcriptional activation of the human immunodeficiency virus long terminal repeat by protein kinase inhibitors.
Brown FL; Tahaoglu E; Graham GJ; Maio JJ
Mol Cell Biol; 1993 Sep; 13(9):5245-54. PubMed ID: 8355680
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of a human T-cell clone with anti-CD3 or tumor necrosis factor induces NF-kappa B translocation but not human immunodeficiency virus 1 enhancer-dependent transcription.
Hazan U; Thomas D; Alcami J; Bachelerie F; Israel N; Yssel H; Virelizier JL; Arenzana-Seisdedos F
Proc Natl Acad Sci U S A; 1990 Oct; 87(20):7861-5. PubMed ID: 2146676
[TBL] [Abstract][Full Text] [Related]
15. Repression of the hepatitis B virus enhancer by a cellular factor.
Spandau DF; Lee CH
J Gen Virol; 1992 Jan; 73 ( Pt 1)():131-7. PubMed ID: 1730933
[TBL] [Abstract][Full Text] [Related]
16. Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases.
Cross JC; Wen P; Rutter WJ
Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8078-82. PubMed ID: 8367466
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.
Duh EJ; Maury WJ; Folks TM; Fauci AS; Rabson AB
Proc Natl Acad Sci U S A; 1989 Aug; 86(15):5974-8. PubMed ID: 2762307
[TBL] [Abstract][Full Text] [Related]
18. Activation of the human immunodeficiency virus long terminal repeat by herpes simplex virus type 1 is associated with induction of a nuclear factor that binds to the NF-kappa B/core enhancer sequence.
Gimble JM; Duh E; Ostrove JM; Gendelman HE; Max EE; Rabson AB
J Virol; 1988 Nov; 62(11):4104-12. PubMed ID: 2845125
[TBL] [Abstract][Full Text] [Related]
19. Basal and Tat-transactivated expression from the human immunodeficiency virus type 1 long terminal repeat in human placental trophoblast rules out promoter-enhancer activation as the partial block to viral replication.
Zachar V; Ebbesen P; Thomas RA; Zacharova V; Goustin AS
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1461-8. PubMed ID: 8207411
[TBL] [Abstract][Full Text] [Related]
20. The genome of hepatitis B virus contains a second enhancer: cooperation of two elements within this enhancer is required for its function.
Yuh CH; Ting LP
J Virol; 1990 Sep; 64(9):4281-7. PubMed ID: 2166817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
